Motilal Oswal Picks Ipca Labs, AU Bank With Up to 42% Upside

BROKERAGE-REPORTS
Whalesbook Logo
AuthorKavya Nair|Published at:
Motilal Oswal Picks Ipca Labs, AU Bank With Up to 42% Upside
Overview

Motilal Oswal Wealth Management has picked Ipca Laboratories and AU Small Finance Bank as top stocks for the week of March 30, 2026. The firm forecasts significant upside, estimating 14% for Ipca Laboratories and 42% for AU Small Finance Bank. These picks are driven by specific growth factors, including Ipca's expanding domestic and export business and AU Bank's transition to a universal bank.

Motilal Oswal Wealth Management has identified Ipca Laboratories and AU Small Finance Bank as its top stock picks for the week beginning March 30, 2026, citing distinct growth catalysts for each.

Ipca Laboratories Growth Drivers

The pharmaceutical company expects steady earnings growth, fueled by a stronger domestic business and increasing exports. Ipca Laboratories is broadening its domestic offerings with new therapy areas, including cardiology and dermatology, and strengthening its core brands. Export growth is coming from branded markets and a steady ramp-up in generics, especially for U.S. and European tenders. The integration of the Unichem business is moving forward, focusing on cost savings and rebuilding its product pipeline.

AU Small Finance Bank's Universal Bank Vision

AU Small Finance Bank's move to become a universal bank greatly increases its potential market across retail, MSME, and mid-corporate lending. This change provides more portfolio flexibility and cross-selling chances, which should boost long-term returns. A diverse deposit base, better CASA ratio, and a growing network of over 2,700 locations help drive liability growth and operational efficiency. The bank's focus on secured lending and careful underwriting aims to control credit costs and ensure steady profits. Loans are forecast to grow about 24% annually from FY26 to FY28, with earnings projected to increase by roughly 36% annually during the same period.

Disclaimer:This content is for informational purposes only and does not constitute financial or investment advice. Readers should consult a SEBI-registered advisor before making decisions. Investments are subject to market risks, and past performance does not guarantee future results. The publisher and authors are not liable for any losses. Accuracy and completeness are not guaranteed, and views expressed may not reflect the publication’s editorial stance.